Skip to content
  • Tuesday, 29 September 2026
  • 10:58 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Gilead and Nucleai probe why target-positive tumors can still resist ADCs
Laboratory Automation & Robotics

Gilead and Nucleai probe why target-positive tumors can still resist ADCs

Lana Keisha Sep 29, 2026 0

Antibody-drug conjugates (ADCs) have fundamentally transformed the landscape of modern oncology, evolving from a theoretical "magic bullet" concept into a…

Read More
Laboratory Automation & Robotics

Pharma commercial vendor selection still runs on word of mouth: A Harvard MBA student aims to change that with Rx Almanac

Lana Keisha Sep 26, 2026 0

For pharmaceutical companies navigating the complex journey from clinical trial success to market launch, the final hurdle is often the…

Read More
Laboratory Safety & Compliance

Part 1: The Patient Still Needs a CBC: How the CDC Changed the Way We Think About Testing Patients with Ebola and Other Viral Hemorrhagic Fevers

Layla Zulfa Sep 26, 2026 0

The 2014 West African Ebola epidemic served as a crucible for global healthcare systems, exposing significant fractures in laboratory biosafety…

Read More
Laboratory Automation & Robotics

Pharma commercial vendor selection still runs on word of mouth. A Harvard MBA student aims to change that with Rx Almanac.

Lana Keisha Sep 18, 2026 0

The pharmaceutical industry, a sector defined by rigorous clinical validation and data-driven R&D, paradoxically relies on archaic, informal methods when…

Read More
Laboratory Safety & Compliance

Part 1: The Patient Still Needs a CBC: How the CDC Changed the Way We Think About Testing Patients with Ebola and Other Viral Hemorrhagic Fevers

Layla Zulfa Sep 18, 2026 0

The 2014 West African Ebola epidemic served as a crucible for global public health, fundamentally altering the trajectory of laboratory…

Read More
Laboratory Automation & Robotics

Gilead and Nucleai probe why target-positive tumors can still resist ADCs

Lana Keisha Sep 17, 2026 0

Antibody-drug conjugates (ADCs) have fundamentally transformed the landscape of modern oncology, offering a sophisticated "seek-and-destroy" mechanism that couples the precision…

Read More
Laboratory Automation & Robotics

Pharma commercial vendor selection still runs on word of mouth: A Harvard MBA student aims to change that with Rx Almanac.

Lana Keisha Sep 11, 2026 0

For pharmaceutical companies navigating the complex transition from clinical research to commercial launch, the selection of service providers—ranging from distribution…

Read More
Laboratory Safety & Compliance

Part 1: The Patient Still Needs a CBC: How the CDC Changed the Way We Think About Testing Patients with Ebola and Other Viral Hemorrhagic Fevers

Layla Zulfa Sep 11, 2026 0

The 2014 West African Ebola epidemic served as a watershed moment for global healthcare infrastructure, exposing profound vulnerabilities in how…

Read More
Environmental & Analytical Chemistry

Tweaks to leaves and vessels allow trees to still get water to their crowns in dry times

Abdurrohim Arsyad Jul 4, 2026 0

A groundbreaking study, conducted by a team of international researchers, has challenged long-held scientific assumptions about how giant trees manage…

Read More
Biotech & Genetic Research

Are you still using housekeeping proteins for western blot normalization? It’s time for an upgrade.

Jia Lissa Jul 3, 2026 0

Western blotting stands as an indispensable technique in the vast landscape of life science research, serving as a critical tool…

Read More

Posts pagination

1 2
Environmental Impact of Fireworks: New Research Reveals Long-Term Air and Water Contamination RisksThe Owl, the Hutia, and the Bee: Ancient Cave Reveals Unexpected Nesting HabitsLong-Term Caffeinated Coffee and Tea Consumption Linked to Reduced Dementia Risk and Better Cognitive Preservation in Large Scale Prospective StudyScience News: A Century of Independent Scientific Journalism and Public Engagement
Japan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must Have
Dual-Drug Therapy Breakthrough Offers New Hope for Acute Myelogenous Leukemia Patients in Landmark Ludwig Cancer Research StudyMolten Salt Breakthrough: Oak Ridge Researchers Convert Common Plastic Waste Into Gasoline and Diesel at Low TemperaturesDaiichi Sankyo and Merck Voluntarily Withdraw US Application for Lung Cancer Drug Ifinatamab Deruxtecan Following FDA DiscussionsScience News: A Century of Independent Scientific Journalism and the Evolution of Public Literacy
YOU MAY HAVE MISSED
Stem Cell & Regenerative Medicine
Dual-Drug Therapy Breakthrough Offers New Hope for Acute Myelogenous Leukemia Patients in Landmark Ludwig Cancer Research Study
Dwi Wanna Sep 29, 2026
Advanced Materials Science
Molten Salt Breakthrough: Oak Ridge Researchers Convert Common Plastic Waste Into Gasoline and Diesel at Low Temperatures
Nila Kartika Wati Sep 29, 2026
Pharmaceutical R&D
Daiichi Sankyo and Merck Voluntarily Withdraw US Application for Lung Cancer Drug Ifinatamab Deruxtecan Following FDA Discussions
Teuku Ryan Sep 29, 2026
Environmental & Analytical Chemistry
Science News: A Century of Independent Scientific Journalism and the Evolution of Public Literacy
Abdurrohim Arsyad Sep 29, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ